Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Yanqiu WuJiangyue QinJunyun HeYongchun ShenHao WangYanping LiQianglin ZengJiajia DongYunfei AnShuguang XiongMei FengFu-Qiang WenPublished in: International journal of chronic obstructive pulmonary disease (2020)
These results suggested that endostatin is a biomarker for COPD and associated with lower lung function, exacerbation, and systemic inflammation. Endostatin potentially contributes to the pathogenesis of COPD.